WallStreetZenWallStreetZen

NASDAQ: KYTX
Kyverna Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KYTX past revenue growth

How has KYTX's revenue growth performed historically?
Company
-100%
Industry
144.63%
Market
17.55%
KYTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KYTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

KYTX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$60.4M
Current Profit Margin
0%

KYTX Return on Equity

Insufficient data to display

Be the first to know when KYTX announces earnings.

KYTX Return on Assets

Current Company
-85%
Current Industry
2.9%
KYTX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KYTX Return on Capital Employed

Current Company
-108.75%
Current Industry
19.5%

KYTX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KYTX$0.00-$56.75M-$60.37M-100.00%N/A
ENGNN/AN/AN/AN/AN/A
PHAR$266.65M$4.25M-$11.47M+11.91%N/A
IRON$0.00-$75.94M-$76.43MN/AN/A
YMAB$84.82M-$24.94M-$21.43M+145.62%N/A
View Top Biotech Stocks

Kyverna Therapeutics Earnings & Revenue FAQ

What were KYTX's earnings last quarter?

Kyverna Therapeutics (NASDAQ: KYTX) reported Q4 2023 earnings per share (EPS) of -$26.86, up 67.88% year over year. Total Kyverna Therapeutics earnings for the quarter were -$20.67 million. In the same quarter last year, Kyverna Therapeutics's earnings per share (EPS) was -$16.00.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.

What was KYTX's earnings growth in the past year?

As of Q2 2024, Kyverna Therapeutics's earnings has grown year over year. Kyverna Therapeutics's earnings in the past year totalled -$60.37 million.

What was KYTX's revenue last quarter?

Kyverna Therapeutics (NASDAQ: KYTX) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Kyverna Therapeutics's revenue was $282.00 thousand.

What was KYTX's revenue growth in the past year?

As of Q2 2024, Kyverna Therapeutics's revenue has grown -100% year over year. This is 244.63 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Kyverna Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.